+1-(877) 629-3710 cs@conferencepanel.com

Aug 25, 2026 , 01 : 00 PM EST |  152 Days Left

Sterile Filtration of Pharmaceutical Products - Validation and Regulatory Requirements

Presented by Roger Cowan
Duration - 60 Minutes

Join our mailing list
Click here* to download our Order Form

Choose Your Options

Live Webinar
$219
Recorded Webinar
$219
Live & Recorded Webinar
$389
Transcript (Pdf)
$219
Recorded Webinar & Transcript (Pdf)
$389
Live + Recording + Transcript
$429
Live + Transcript
$389
Total $0.00

Description

Sterile filtration is one of the most critical steps in sterile pharmaceutical manufacture. This is because the filtration process provides the assurance of sterility in the finished drug product. Therefore, the design, validation, and ongoing monitoring of a sterile filtration system are essential for assuring the quality and safety of the pharmaceutical product. Proper understanding and testing of the sterile filtration system according to international regulatory standards are important for both the validation and ongoing monitoring of the system.

Areas Covered

  • Sterile Filtration - Importance of Quality
  • Sterility Assurance of Sterile Filtration
  • Sterile Filtration System Design
  • Discussion of Different Filtration Media Properties and Retention Mechanisms
  • Methods for Sterilization of Filters
  • Validation of Sterile Filter Systems
  • Microbial Retention Challenge Testing
  • Integrity Testing
  • Product Compatibility Testing
  • Extractable/Leachable Testing
  • Regulatory Requirements.

Why Should You Attend

It is important that the sterile filtration process is fully understood and properly validated for your particular application. The process requirements and validation needs differ based on the filtration requirement. This webinar will give you a comprehensive understanding of this important subject with an emphasis on the different types of sterilizing filtration available and their application to your particular system. For example, the application of sterile filtration to use-point compressed air is discussed in detail.

A review of the different filtration media is provided, with the construction characteristics and properties of each detailed. A detailed description of a typical pharmaceutical sterile filtration system with its individual components is provided. Engineering schematics are included. Microbiology and particle retention mechanisms are discussed. 

Integrity testing methods are detailed, as well as media qualification. Procedures for the sterilization of the filter are presented (SIP, autoclave, etc.). 

The proper validation of sterile filtration is important to ensure that the filter will reproducibly remove undesirable components (bioburden) while allowing passage of desirable components (drug product). The operating parameters of time, pressure, and temperature are fully discussed, as well as the filter's potential effect on the product (compatibility, leachables, fibers, endotoxin, etc.).  Microbial retention challenge testing is one of the validation requirements.

Finally, a compilation of all FDA/EU GMP regulatory guidances concerning sterile filtration is presented. Related to this, the responsibilities of the filter manufacturer vs. the filter user are fully discussed.

Who Should Attend

This webinar will provide valuable assistance to all personnel in:

  • Quality Assurance
  • Environmental Monitoring
  • Microbiology
  • Manufacturing
  • Validation
  • Engineering
  • Maintenance.

Speaker

Roger Cowan

Roger Cowan is the founder and owner of R Cowan Consulting Services LLC, a consulting company specializing primarily in pharmaceutical contract manufacturing. He has 35 years of experience in pharmaceutical quality assurance and manufacturing. In his career, Roger has held various manager/director positions in Quality Assurance, QC Laboratory, Technical Services Validation, Manufacturing, and Clinical Supply manufacturing and distribution. Roger has taught courses in microbiology at Seneca College (Pharmaceutical Technology Program) in Toronto, Canada.   

Roger's areas of expertise include aseptic pharmaceutical manufacture, GMP facility audits, technical transfer, microbiology, environmental monitoring/contamination control, product sterilization, process development, process validation, clinical supply manufacturing, labeling and distribution, US / International regulatory requirements, regulatory submissions, and quality assurance/control.